SENSEX 75,516.73
NIFTY 23,614.90
CRUDEOIL 8,870.00
GOLD 141,902.00
SILVER 218,335.00
Cipla shares soared 3.7% on Friday despite a 39% decline in first-quarter PAT, with the stock trading at ₹1,426.40 on the NSE.
Cipla reported Q1 PAT down 39% to ₹789 crore YoY, though shares gained 3.7% on hopes of a US market turnaround despite broker skepticism. Delayed $1B US target to FY28 and falling EBITDA margins expose execution risk; most analysts maintain downgrade, signaling headwinds ahead.
SENSEX 75,516.73
NIFTY 23,614.90
CRUDEOIL 8,870.00
GOLD 141,902.00
SILVER 218,335.00

Cipla Q1 Results: Cons profit drops 39% YoY to Rs 789 crore; revenue rises marginally

Cipla Q1 net dips 39% to ₹785.55 crore as North America business drags

Stocks in news: Infosys, Cipla, Meesho, Suzlon Energy, IndiGo, NTPC

Cipla expects sequential recovery in North America on new product launches despite tariff uncertainty

Cipla shares surged on Thursday, extending gains to nearly 11% in two sessions, after several brokerages turned bullish on the…

Cipla Q1 Results: Pharma major Cipla reported a 39% year-on-year decline in Q1FY27 consolidated net profit to Rs 789 crore,…

Cipla Ltd announced a significant 55% year-on-year drop in its consolidated net profit for the fourth quarter, reaching Rs 555…

The stock traded at ₹3,550.40 on the NSE at 10.20 am after falling to an intraday low of ₹3,471.10 from the previous close of…

Brokerages turned more bullish following the earnings announcement, citing sustained margin improvement, better product mix and…

Cipla's Q1 net profit fell 39% to ₹785.55 crore, impacted by North America sales; growth expected from upcoming products.